Login | Register
Profile | Log out
logo

  • Home
  • News
  • Opinion
  • Other
    • Market Updates
    • Explainers
    • Satire
  • About
  • Contact Us
    • Contact
    • Get Covered
    • Posting Guidelines
  • Subscribe
Submit An Article

Blog

  • Home
  •  
  • Blog



  • Most Read
  • Latest Comments
  • Blog
    • News

    RBA and ASIC up the ante on blockchain project, ASX writes off millions
    Public
  • Blog
    • Satire

    Australia to close borders to Omicron Persei 8
    Public
  • Blog
    • Opinion

    The New Criterion: will the listed sanitiser stocks clean up – or clean out – investors?
    Public
  • Blog
    • Opinion

    Is this the most hated company on the ASX?
    Public
  • Blog
    Opening a new frontier in treating Parkinson’s disease
    • Review
    • November 11, 2022
  • Tremors from the FTX collapse continue to be felt as DigitalX sells off 15% Bitcoin holdings
    • Review
    • January 10, 2023
  • AUDC stablecoin gathers momentum as Novatti confirms integration with XRP Ledger
    • Review
    • June 9, 2022
  • PharmAust completes dosing first cohort for MND treatment, patients respond positively
    • Review
    • January 6, 2023
  • Is this the most hated company on the ASX?
    • Review
    • August 16, 2019

Latest Articles

  • AML3D announces stronger FY26, with positive EBITDA reported in the second half
    AML3D announces stronger FY26, with positive EBITDA reported in the second half
    • News

  • Refurbished tech gives Harris Technology a second life
    Refurbished tech gives Harris Technology a second life
    • News

  • Imagion Biosystems Advances MagSense® Phase 2 Trial
    Imagion Biosystems Advances MagSense® Phase 2 Trial
    • News

  • Acrux-developed Menopause Hormone Therapy to enter Australian market
    Acrux-developed Menopause Hormone Therapy to enter Australian market
    • News

  • Evion Expands Critical Minerals Push with Nevada Fluorspar Option
    Evion Expands Critical Minerals Push with Nevada Fluorspar Option
    • News

  • ResApp expands their diagnostic offering into disease affecting 1 billion worldwide
    • News

    ResApp expands their diagnostic offering into disease affecting 1 billion worldwide

    Experts estimate that sleep apnoea affects nearly 1 billion people worldwide. Every year, 4 million people die prematurely from chronic respiratory diseases such as COPD, asthma, acute respiratory tract infections, tuberculosis and lung cancer.  The global impact of respiratory based ailments is expansive, prompting The World Health Organisation to launch the Global Alliance Against Respiratory

    Read More
    Public
  • Markets set for a muted start to the week
    • News

    Markets set for a muted start to the week

    US markets on Friday closed slightly lower but finished to week higher. We have likely seen the worst of the selling for now as the US has kicked the debt ceiling issues out to December. Investors will likely wait for the reporting to kick off before buying too much more into this market. Fastenal will

    Read More
    Public
  • Rewardle foregoes fees in preference of equity stake in BNPL SplitPay
    • News

    Rewardle foregoes fees in preference of equity stake in BNPL SplitPay

    Give a man a fish, he eats for a day. Teach a man to fish he eats for a lifetime.  This is the mantra being undertaken by marketing tech company Rewardle (ASX: RXH) which is passing on up to $60k worth of fees for a 1% equity stake in buy-now-pay-later operator SplitPay.  At that ratio,

    Read More
    Public
  • US kicks the can out to December
    • News

    US kicks the can out to December

    US markets recovered somewhat overnight after a compromise to extend the debt ceiling to fund operations through to early December. This gives the Democrats some time to come to a longer-term solution to fund the government and bides 3.5 trillion spending agenda. The major US indices did not hold the high for the day, giving

    Read More
    Public
  • Preparing for a banking licence, Novatti increases its stake in proposed neobank
    • News

    Preparing for a banking licence, Novatti increases its stake in proposed neobank

    There is an air of confidence around digital payments company Novatti Group (ASX: NOV) which has increased its equity stake in their neobank subsidiary, giving the Aussie fintech a 70% stake in the business expected to be granted its banking license soon. Already a global financial institution, banking services have been on the agenda for

    Read More
    Public
  • Contraceptive alternatives – Mayne Pharma receives FDA response putting them a step closer to approval
    • News

    Contraceptive alternatives – Mayne Pharma receives FDA response putting them a step closer to approval

    Of the myriad of contraceptives out there, those that don’t require daily effort are gaining in popularity. As our lives get busier and brains get fuller, women are electing for long term, ‘set and forget’ birth control measures. Two thirds of Australian women of reproductive age use birth control. Whilst methods like the oral contraceptive

    Read More
    Public
  • «
  • ‹
  • 451
  • 452
  • 453
  • 454
  • 455
  • ›
  • »

Login or register for free to access unlimited reading

Register Now!
  • News

  • Opinion

  • Satire

  • About

  • Contact Us

  • Subscribe

The content published on this website is solely for general information purposes and is not to be construed as financial advice. Should you seek financial advice you should consult with an appropriately qualified person. Opinions expressed on this site are subject to change without notice and The Sentiment who produced this content is under no obligation to keep the information current. The Sentiment, affiliated companies & associates may have a conflict of interest with companies discussed on the website due to commercial arrangements, for example they may be shareholders in the company, be engaged by them to assist in investor communications or receive commission/brokerage for funds raised.

Copyright © 2020 The Sentiment. All rights reserved.
Subscribe

Enter your email address below to subscribe to The Sentiment’s weekly newsletter, highlighting the top news, research, opinion and satire articles shaping ASX investor sentiment.

The Sentiment respects your privacy and will not spam you. View our privacy policy here.